ArticleThe Journal of dermatology2025

Delayed and immediate cutaneous adverse events during pembrolizumab combination chemotherapy against cervical cancer: Case series.

Takeya Adachi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.